Extrusion International USA 4-2019

24 Extrusion International 4/2019 EXTRUSION INTERNATIONAL INDUSTRY NEWS “Micro Medical” Extrusion Tooling Guill Tool & Engineering Co., Inc. www.guill.com ical crosshead offers great flexibility to its users. It not only accepts both vacuum and micro-air accessories, but is also ideal for pressure and sleeving applications. Fluoropolymer designs are available upon request. For more information: Investment in East Coast U.S. Fund to access NewTechnologies Evonik is extending its corporate venture capital activities in the U.S. with an investment into Tech Council Ventures II. Evonik is investing a single-digit million U.S.-dollar amount. Tech Council Ventures is a U.S.-focused early-stage inves- tor. It finances young, innovative start-up companies and actively supports them with their extended network in the Mid-Atlantic region on the east coast of the U.S. The fund is based in New Brunswick, New Jersey, near Evon- ik’s U.S. headquarters in Parsippany and will enable access to a local network of technology start-ups including aca- demia and industry. The Mid-Atlantic States of New Jersey, Pennsylvania, Delaware, Connecticut, Maryland, Virginia and New York represent the second-largest venture-capital market in the country. In the U.S., Evonik Venture Capital is represented by Lutz Stoeber and Eric Breese, who are responsible for Evonik’s venture capital activities in North America. “The investment underlines our commitment to the re- gion,” said John Rolando, president of North America for Evonik. “We see ourselves as a collaborator to foster entre- preneurship and strengthen local ties.” Tech Council Ventures II focuses on areas that have a close fit to Evonik’s growth engines, areas which the company has identified as promising fields for future growth and development. The fund invests in start-ups in the fields of materials, life sciences, healthcare, internet of things and energy. Evonik Venture Capital plays a strategic role in Evonik’s goal to become a best-in-class specialty chemicals company, by helping secure access to disruptive technologies and inno- vative business models as well as supporting digital trans- formation. To this end, Evonik launched its second venture capital fund with a volume of €150 million at the beginning of 2019, more than doubling the amount under manage- ment to €250 million. Evonik Industries AG www.evonik.de/en Guill Tool & Engineering (West Warwick, Rhode Island) will be exhibiting at the upcoming Extrusion Conference in Chicago (September 17-19, 2019), and the International Elas- tomer Conference in Cleveland (October 8-10, 2019). Guill in- troduces the newMicro Medical, an extrusion crosshead that uses micro-fine adjustment screws for precise concentricity adjustment. The precision of concentricity reaches 0.008” or finer per revolution. This single point concentricity adjust- ment is a unique Guill innovation for the extrusion of thin- walled and precision ID/OD medical tubing. One adjustment bolt controls 360° of adjustment. Features of the Micro Medical crosshead in- clude a patented cam-lock deflector for quick changeovers, with a residence time of one minute at .5 lb/hr material flow, optimized usage with extruders measuring ½” and ¾”, and a max die ID of .250.” Additionally, the Guill Micro Med-